Product Description
Icikinase 1.5MIU Injection is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. The doctor may closely monitor your condition until you become stable.
Use of this medicine may cause injection site bleeding, nausea, allergic reaction, and a decrease in blood pressure. It may increase your risk of bleeding also. Your doctor will explain the benefits and risks associated with this medicine before it is administered. You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.
This medicine is used with caution for some people. Thus, you must inform the doctor if you are suffering from any bleeding disorder, kidney, or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.
Thrombolytic Power for Acute CareIcikinase delivers potent thrombolytic action ideal for conditions like heart attacks and pulmonary embolism, rapidly dissolving clots to restore normal blood flow. As an allopathic, prescription medication, its efficacy is supported by clinical approval, ensuring safe intervention when administered by healthcare professionals under controlled environments.
Simple and Effective AdministrationThis lyophilized powder is straightforward to prepare: reconstitute with supplied sterile water and administer intravenously per medical guidance. Designed for adults, its standardized 1,500,000 IU dosage ensures consistent therapeutic effect, easing physician workflow and enhancing patient safety during acute interventions.
Safety and Storage MeasuresIcikinase must be stored below 25C and protected from light to preserve its potency. With robust cautions for those with bleeding tendencies or recent cerebrovascular incidents, proper patient selection and monitoring safeguard against adverse effects, making it a reliable option for qualified adults.
FAQ's of Icikinase 1500000 Iu Inj:
Q: How is Icikinase 1500000 IU Injection administered to patients?
A: Icikinase is administered intravenously after reconstituting the white to off-white lyophilized powder using the supplied sterile water for injection. Only qualified healthcare professionals should perform the administration following the recommended dosage and physician's direction.
Q: What conditions is Icikinase indicated to treat?
A: Icikinase is primarily recommended for adults diagnosed with acute myocardial infarction, pulmonary embolism, and deep vein thrombosis. It functions as a thrombolytic agent to dissolve dangerous blood clots in the circulatory system.
Q: When should Icikinase not be used?
A: Icikinase is contraindicated in patients who have active internal bleeding, a history of cerebrovascular accident, or known hypersensitivity to streptokinase. It is also unsuitable for those with recent surgery or hemorrhagic stroke due to increased bleeding risk.
Q: Where should Icikinase be stored before use?
A: The product should be stored below 25C, protected from light, and not frozen, to maintain its effectiveness throughout the 24-month shelf life from the date of manufacture.
Q: What is the process for preparing Icikinase before injection?
A: To prepare Icikinase, the lyophilized powder is reconstituted in the vial using the sterile water for injection provided in the packaging, ensuring the mixture is fully dissolved before intravenous administration.
Q: What benefits does Icikinase offer in medical emergencies?
A: Icikinase rapidly dissolves blood clots, making it invaluable in emergencies such as heart attacks and pulmonary embolism, by restoring blood flow and reducing the risk of permanent damage.
Q: How is patient safety ensured during Icikinase therapy?
A: Patient safety is maintained through careful screening for contraindications, monitoring for allergic reactions and bleeding, and administering the medication only under strict medical supervision.